STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight […]

STOCKHOLM — Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in preventing major kidney disease, cardiovascular events, as well as mortality in patients […]

The European Renal Association (ERA) kicks off its 61st ERA Congress in Stockholm, Sweden, with a theme of “Rethinking kidney health, transforming kidney care,” and a […]

(Reuters) – A man with end-stage renal disease who earlier this year became the first human to receive a new kidney from a genetically modified pig […]

FRANKFURT (Reuters) – The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United States, could rise by as much […]

Cisplatin is a preferred treatment for a wide range of cancers, including breast, head and neck, lung, ovary, and more. However, its side effects — particularly […]

Older men with chronic kidney disease (CKD) show higher resting muscle sympathetic nerve activity, but not vascular stiffness, compared with older women, offering clues to the […]